Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2022-03-25 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2022 - Special Report by the Board (art. 7-199) (23 feb 2022) - signed.pdf
Share Issue/Capital Change Classification · 1% confidence The document is explicitly titled "SPECIAL REPORT BY THE BOARD OF DIRECTORS TO THE SHAREHOLDERS on the use and purpose of the authorized capital" and states it is "prepared in accordance with article 7:199 of the Belgian Code of Companies and Associations". This document details the proposal to renew the Board's powers to increase the share capital, which directly relates to the company's capital structure and financing authorization. This fits the description of a document concerning capital/financing activities, specifically related to shareholder authorization for capital changes. While it discusses capital, it is a formal report presented to shareholders regarding the authorization framework, not a general earnings release (ER) or a comprehensive interim/annual report (IR/10-K). It is a specific report detailing capital structure management, which aligns best with the 'Capital/Financing Update' (CAP) category, as it is a proposal/report seeking approval for future capital actions, or potentially a specialized report that might fall under 'Governance Information' (CGR) due to its statutory nature, but the core subject is capital authorization. Given the focus on renewing powers to issue shares, convertible bonds, or warrants, 'CAP' (Capital/Financing Update) is the most precise fit among the provided options for a statutory report detailing capital authorization limits and purposes.
2022-03-25 English
Proxy General Meeting 28 avril 2022 - FR - FINAL.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is explicitly titled "PROCURATION POUR L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES DU 28 AVRIL 2022" (Proxy for the General Shareholders' Meeting of April 28, 2022). It contains instructions for shareholders on how to appoint a proxy, vote by mail, and details the agenda items for both the Ordinary and Extraordinary parts of the meeting, including resolutions on financial reports, remuneration, director re-elections, and capital structure changes. This material is designed to solicit shareholder votes and provide necessary information ahead of the meeting, which perfectly matches the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an AGM, the document itself is the proxy form/information statement, not the AGM presentation (AGM-R) or the final voting results (DVA).
2022-03-25 French
Proxy General Meeting 28 April 2022 - DUTCH - FINAL.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 28 APRIL 2021 OM 11:00 UUR (BELGISCHE TIJD)" which translates to "PROXY FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF APRIL 28, 2021 AT 11:00 AM (BELGIAN TIME)". The content consists of a proxy form for shareholders to appoint a representative and provide voting instructions for various agenda items, including the approval of the annual accounts, remuneration report, and renewal of director mandates. This material is directly related to soliciting votes and providing information ahead of the Annual General Meeting (AGM). While it is a proxy/voting instruction document, the closest and most specific category covering AGM materials and related voting solicitation is AGM Information (AGM-R) or Proxy Solicitation & Information Statement (PSI). Since this document is explicitly a 'Volmacht' (Proxy) form used to facilitate voting at the AGM, PSI is the most precise fit, as it covers materials sent to shareholders to request votes. However, AGM-R covers 'Presentations and materials shared during the Annual General Meeting (AGM)'. Given the context of a proxy form being a core material for the meeting itself, and the presence of voting items, PSI is slightly more accurate than AGM-R, which often implies presentations given *at* the meeting. Reviewing the definitions, PSI (Proxy Solicitation & Information Statement) is the best fit for a proxy form.
2022-03-25 Dutch
UCB SA_Board of Directors report_12_2021 EN - FINAL.pdf
Annual Report Classification · 1% confidence The document is titled 'Annual report of the Board of Directors for the financial year ended 31 December 2021' for UCB SA/NV. It contains detailed financial information, including balance sheet items, profit and loss analysis, and proposed dividend distributions for the statutory entity. While it references the 'UCB Group Integrated Annual Report 2021' for consolidated data, this specific document serves as the statutory annual report for the parent company, providing substantive financial data and management analysis. Therefore, it is classified as an Annual Report (10-K). FY 2021
2022-03-25 English
UCB_SA_Report_KAM EN_final.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled 'Statutory auditor's report to the general shareholders' meeting of UCB SA on the annual accounts for the year ended 31 December 2021'. It contains the auditor's opinion, key audit matters, and responsibilities, which are the defining characteristics of an Audit Report (AR). It is not the full Annual Report (10-K) itself, but rather the standalone audit opinion document. FY 2021
2022-03-25 English
2021 UCB Integrated Annual Report - FR.pdf
Annual Report Classification · 1% confidence The document is titled 'Rapport annuel intégré 2021 UCB' (UCB 2021 Integrated Annual Report). It contains comprehensive financial data, management reports, governance disclosures, and audit reports for the full fiscal year 2021. It explicitly states it includes the management report, financial statements, and corporate governance declarations required by Belgian law. As it is the primary annual reporting document for the company, it is classified as a 10-K (Annual Report). FY 2021
2022-03-25 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.